Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abilify 10mg tablets
0402010ADBBAAAA
|
Abilify | Aripiprazole | Central Nervous System | 1,085 |
|
Oxycodone 80mg modified-release tablets
0407020ADAAAIAI
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,075 |
|
Riluzole 25mg/5ml oral suspension sugar free
0409030R0AAADAD
|
Riluzole | Riluzole | Central Nervous System | 1,066 |
|
Mintreleq XL 50mg tablets
0402010ABBJAAAV
|
Mintreleq XL | Quetiapine | Central Nervous System | 1,061 |
|
Imigran 10mg nasal spray
0407041T0BBAHAH
|
Imigran | Sumatriptan succinate | Central Nervous System | 1,059 |
|
Pimozide 4mg tablets
0402010R0AAABAB
|
Pimozide | Pimozide | Central Nervous System | 1,052 |
|
Oxycodone 50mg/1ml solution for injection ampoules
0407020ADAAANAN
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,050 |
|
Rebrikel 5micrograms/hour transdermal patches
0407020B0BVAAAH
|
Rebrikel | Buprenorphine | Central Nervous System | 1,048 |
|
Reltebon 20mg modified-release tablets
0407020ADBKACAG
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,047 |
|
Pipexus 1.57mg modified-release tablets
0409010W0BEAEAJ
|
Pipexus | Pramipexole | Central Nervous System | 1,044 |
|
Actimorph 2.5mg orodispersible tablets
0407020Q0BQAAGE
|
Actimorph | Morphine sulfate | Central Nervous System | 1,043 |
|
Atomoxetine 4mg/ml oral solution sugar free
0404000S0AAAKAK
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 1,043 |
|
Elvanse Adult 40mg capsules
0404000U0BDAEAC
|
Elvanse Adult | Lisdexamfetamine dimesylate | Central Nervous System | 1,041 |
|
Alzest 13.3mg/24hours transdermal patches
0411000E0BGACAI
|
Alzest | Rivastigmine | Central Nervous System | 1,040 |
|
Lormetazepam 500microgram tablets
0401010P0AAABAB
|
Lormetazepam | Lormetazepam | Central Nervous System | 1,037 |
|
Abstral 100microgram sublingual tablets
0407020A0BJAAAW
|
Abstral | Fentanyl | Central Nervous System | 1,035 |
|
Co-careldopa 10mg/100mg tablets
0409010N0AAAAAA
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 1,031 |
|
Venaxx XL 75mg capsules
0403040W0BLAAAD
|
Venaxx | Venlafaxine | Central Nervous System | 1,029 |
|
Imigran 20mg nasal spray
0407041T0BBAGAG
|
Imigran | Sumatriptan succinate | Central Nervous System | 1,026 |
|
Depalta 30mg gastro-resistant capsules
0403040Y0BDAAAA
|
Depalta | Duloxetine hydrochloride | Central Nervous System | 1,023 |
|
Matoride XL 36mg tablets
0404000M0BHAAAN
|
Matoride | Methylphenidate hydrochloride | Central Nervous System | 1,023 |
|
Amfexa 20mg tablets
0404000L0BGACBP
|
Amfexa | Dexamfetamine sulfate | Central Nervous System | 1,022 |
|
Targinact 5mg/2.5mg modified-release tablets
0407020AFBBACAC
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,020 |
|
Lynlor 20mg capsules
0407020ADBHACAE
|
Lynlor | Oxycodone hydrochloride | Central Nervous System | 1,016 |
|
Ationdo SR 100mg tablets
0407020AGBCACAD
|
Ationdo | Tapentadol | Central Nervous System | 1,008 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.